This post-approval study has not been publically released by the fda. It may be a place-holder supplement number.
| Device | P170038S004 |
| Classification Name | None |
| Applicant | |
| PMA | P170038 |
| Supplement | S004 |
| Supplement Number | Date | Supplement Type |
|---|---|---|
| P170038 | Original Filing | |
| S010 | 2022-04-13 | 30-day Notice |
| S009 | 2022-03-15 | 30-day Notice |
| S008 | 2021-08-24 | 135 Review Track For 30-day Notice |
| S007 | 2021-08-02 | Normal 180 Day Track No User Fee |
| S006 | 2021-07-08 | 30-day Notice |
| S005 | 2020-07-31 | Normal 180 Day Track No User Fee |
| S004 | ||
| S003 | 2020-04-01 | 30-day Notice |
| S002 | ||
| S001 | 2020-01-08 | Normal 180 Day Track No User Fee |